Epigenetics and Epigenomics in Health and Disease

Illumina is sponsoring Epigenetics and Epigenomics in Health and Disease Conference and will have a symposium at the conference. Our Symposium will be on Thursday 17 November 15:40-16:00 and will be titled Implication of the H2B Monoubiquitination Signaling in Female Cancers. Our Speaker will be Dr. Florian Wegwitz from Laboratory for Molecular Gynecology at University Medical Center Göttingen.

This International Meeting on “Epigenetics and Epigenomics in Health and Disease” will integrate different sessions on: transcription and chromatin in gene regulation, DNA modifications, RNA epigenetics, non-coding RNA, epigenomic tools. Besides bringing the newest findings on epigenetic mechanisms, a special focus will be dedicated to discuss novel and promising therapeutic drugs aimed at reversing specific epigenetic alterations.

The meeting will gather scientists using diverse approaches, such as molecular biology, cell biology genetics, epigenomics, and biochemistry. Researchers from pharmaceutical companies and clinicians working in different fields but sharing the same interests will also find the meeting an ideal opportunity to meet, discuss and summarize their work.